Why America’s opioid epidemic is going global
Purdue Pharma, the maker of OxyContin, declared bankruptcy as part of a tentative deal to settle more than 2,000 lawsuits alleging that they and other opioid manufacturers worsened the US opioid epidemic. But the opioid crisis is not just an American problem; it’s a global one. "How to Sell Drugs," Quartz’s newest investigative documentary, examines the marketing practices of Mundipharma, Purdue Pharma’s overseas arm. Quartz journalists visited France, Pakistan, and The Netherlands to uncover how the company is marketing opioids abroad. -- Become a member of Quartz, your exclusive guide to the global economy: qz.com/become-a-member/?utm_source=youtube&utm_medium=opioids&utm_campaign=101&utm_content=description_member WATCH OUR EXCLUSIVE SERIES; Because China qz.com/se/because-china/?utm_source=youtube&utm_medium=opioids&utm_campaign=101&utm_content=description_series Quartz is a digital news outlet dedicated to telling stories at the intersection of the important and the interesting. Visit us at qz.com/ to read more.
